Skip to Main Content
Insider Trading

Last Updated: 4 days, 20 hours ago

Bratin Saha has an estimated net worth of at least $12.7 million*, as of Sept. 10, 2025. They own 269,465 shares of DOCN stock. They have sold 97,096 shares of DOCN stock since 2021, for an estimated $3.1 million.

Bratin Saha $DOCN SEC Form 4 Insider Trading

Bratin Saha has filed a total of 10 insider trades in $DOCN since 2021. Their most recent trade was a sale of 13,010 shares, made on Sep 03, 2025. Their largest trade was a sale of 41,541 shares, made on Jun 03, 2025. We estimate that they now own 269,465 shares of $DOCN, worth an estimated $9.6 million.



Insider Trading at $DOCN

There have been a total of 79 insider trades reported at $DOCN since 2021, with 4,000 shares purchased and 6.5 million shares sold. The most active insider traders in $DOCN stock have been Jeffrey Scott Guy, Bratin Saha, and Alan Shapiro. The most recent trade was a sale of 13,010 shares reported by Bratin Saha (Chief Product & Tech Officer), made on Sep 03, 2025.



History of Insider Stock Trades by Bratin Saha

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
DOCN logo DOCN Sale 13,010 Sep 03, 2025 Sept. 3, 2025, 4:37 p.m.
DOCN logo DOCN Sale 3,461 Jun 18, 2025 June 18, 2025, 4:28 p.m.
DOCN logo DOCN Sale 41,541 Jun 03, 2025 June 3, 2025, 4:56 p.m.
DOCN logo DOCN Sale 3,461 May 20, 2025 May 20, 2025, 4:19 p.m.
DOCN logo DOCN Sale 3,461 Apr 21, 2025 April 21, 2025, 4:25 p.m.
DOCN logo DOCN Sale 3,948 Mar 18, 2025 March 19, 2025, 4:16 p.m.
DOCN logo DOCN Sale 4,289 Jan 21, 2025 Jan. 22, 2025, 5:16 p.m.
DOCN logo DOCN Sale 3,468 Dec 18, 2024 Dec. 19, 2024, 5:15 p.m.
DOCN logo DOCN Sale 16,989 Nov 18, 2024 Nov. 19, 2024, 5:15 p.m.
DOCN logo DOCN Sale 3,468 Nov 19, 2024 Nov. 19, 2024, 5:15 p.m.




$DOCN Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.